APO TP 200 (Topiramate 200 mg)

Pill imprint APO TP 200 has been identified as Topiramate 200 mg.

Topiramate is used in the treatment of obesity; migraine prevention; bipolar disorder; fibromyalgia; vulvodynia (and more), and belongs to the drug class carbonic anhydrase inhibitor anticonvulsants. There is positive evidence of human fetal risk during pregnancy. Topiramate 200 mg is not subject to the Controlled Substances Act.

See also related documents.

Imprint Search

Images for APO TP 200

Topiramate 200 mg APO TP 200
Topiramate 200 mg APO TP 200
Topiramate
Imprint:
APO
TP 200
Strength:
200 mg
Color:
Brown
Shape:
Round
Availability:
Prescription only
Drug Class:
Carbonic anhydrase inhibitor anticonvulsants
Pregnancy Category:
D - Positive evidence of risk
CSA Schedule:
N - Not a controlled drug
Manufacturer:
Apotex Corp.
National Drug Code (NDC):
60505-2763
Inactive Ingredients:
silicon dioxide
croscarmellose sodium
hydroxypropyl cellulose
hypromellose 2910 (5 mPa.s)
magnesium stearate
methylcellulose (15 mPa.s)
polyethylene glycol 8000
titanium dioxide
ferric oxide red

View Details Print Page

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2014 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide
(web2)